Bio-Rad Labs (BIO) Tops Q2 EPS by 58c
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $376.64 -1.51%
EPS Growth %: -1.3%
Financial Fact:
Weighted average common shares - basic: 29.4M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: -1.3%
Financial Fact:
Weighted average common shares - basic: 29.4M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q2 EPS of $3.38, $0.58 better than the analyst estimate of $2.80. Revenue for the quarter came in at $691.1 million versus the consensus estimate of $682.62 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Ready Capital prices $225M in new notes, redeems $350M due 2026
- Circle Internet stock climbs on TD Cowen upgrade, Fed rate hike
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
